Literature DB >> 11691786

The presence of single nucleotide instability in human breast cancer cell lines.

N Watanabe1, E Okochi, M Mochizuki, T Sugimura, T Ushijima.   

Abstract

The presence of single nucleotide instability, an increase of spontaneous point mutation rates (MR: number of mutations per cell division) without microsatellite instability, was demonstrated previously in two rat mammary carcinoma cell lines. In this study, spontaneous point MRs were analyzed in human breast cancer cell lines by the fluctuation test using the hypoxanthine-guanine phosphoribosyltransferase (hprt) marker gene. MRs obtained for six breast cancer cell lines, MCF-7, ZR-75-1, T-47D, MDA-MB-231, MDA-MB-468, and BT-474, all of which were proficient in G/T mismatch binding and reported to be negative for microsatellite instability, were 7.6, 4.6, 6.3, 2.2, 5.6, and 19 x 10(-7) mutations/hprt/cell division. Those in normal human mammary epithelial cells and in a colon cancer cell line with proficient mismatch repair, SW480, were 1.6 and 1.4 x 10(-7) mutations/hprt/cell division, respectively. These findings showed that single nucleotide instability was also present in five of the six human breast cancer cell lines and strongly indicates it has important roles in human and rat mammary carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11691786

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  A fabricated siRNA nanoparticle for ultra-long gene silencing in vivo.

Authors:  Seung Koo Lee; Ching-Hsuan Tung
Journal:  Adv Funct Mater       Date:  2013-07-26       Impact factor: 18.808

2.  Cellular uptake evaluation of pentagamaboronon-0 (PGB-0) for boron neutron capture therapy (BNCT) against breast cancer cells.

Authors:  Adam Hermawan; Ratna Asmah Susidarti; Ratna Dwi Ramadani; Lailatul Qodria; Rohmad Yudi Utomo; Miki Ishimura; Yoshihide Hattori; Yoichiro Ohta; Mitsunori Kirihata; Edy Meiyanto
Journal:  Invest New Drugs       Date:  2019-03-30       Impact factor: 3.850

3.  Genetic instability favoring transversions associated with ErbB2-induced mammary tumorigenesis.

Authors:  Shiquan Liu; Wenjing Liu; John L Jakubczak; Gregory L Erexson; Kenneth R Tindall; Richard Chan; William J Muller; Sankar Adhya; Susan Garges; Glenn Merlino
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

4.  Rapid 3D Extrusion of Synthetic Tumor Microenvironments.

Authors:  Joshua M Grolman; Douglas Zhang; Andrew M Smith; Jeffrey S Moore; Kristopher A Kilian
Journal:  Adv Mater       Date:  2015-08-18       Impact factor: 30.849

5.  Exometabolom analysis of breast cancer cell lines: Metabolic signature.

Authors:  Lucas Willmann; Thalia Erbes; Sebastian Halbach; Tilman Brummer; Markus Jäger; Marc Hirschfeld; Tanja Fehm; Hans Neubauer; Elmar Stickeler; Bernd Kammerer
Journal:  Sci Rep       Date:  2015-08-21       Impact factor: 4.379

6.  The absence of Mth1 inactivation and DNA polymerase kappa overexpression in rat mammary carcinomas with frequent A:T to C:G transversions.

Authors:  Eriko Okochi; Shizue Ichimura; Takashi Sugimura; Toshikazu Ushijima
Journal:  Jpn J Cancer Res       Date:  2002-05

7.  Curcumin-loaded nanoliposomes linked to homing peptides for integrin targeting and neuropilin-1-mediated internalization.

Authors:  Sogol Kangarlou; Sorour Ramezanpour; Saeed Balalaie; Shahla Roudbar Mohammadi; Ismaeil Haririan
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

Review 8.  Targeting purine metabolism in ovarian cancer.

Authors:  Jingchun Liu; Shasha Hong; Jiang Yang; Xiaoyi Zhang; Ying Wang; Haoyu Wang; Jiaxin Peng; Li Hong
Journal:  J Ovarian Res       Date:  2022-08-13       Impact factor: 5.506

Review 9.  Mitosis-targeted anti-cancer therapies: where they stand.

Authors:  K-S Chan; C-G Koh; H-Y Li
Journal:  Cell Death Dis       Date:  2012-10-18       Impact factor: 8.469

10.  Engineering a 3D microfluidic culture platform for tumor-treating field application.

Authors:  Andrea Pavesi; Giulia Adriani; Andy Tay; Majid Ebrahimi Warkiani; Wei Hseun Yeap; Siew Cheng Wong; Roger D Kamm
Journal:  Sci Rep       Date:  2016-05-24       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.